Ann: Dimerix Confirms Phase 3 FSGS Study Design With EMA, page-5

Yes very positive
Would DXB be progressing like this :

The Phase 3 protocol proposal is also under review by the FDA and MHRA (UK regulatory agency), and
a virtual meeting between the FDA and Dimerix has been scheduled to confirm that specific study
design endpoints also meet the criteria required to support accelerated approval for FSGS in the US.
Once confirmed, Dimerix can begin initiating clinical sites globally and subsequent recruitment of
patients, which is expected early Q3-2021.

without funding lined up??

or are they banking on one of the two covid study outcomes providing SP support to fund?
I hope we get news soon regarding funding and my hope is that Big Pharma are in discussions. Cheers.